Protein expression and functional analysis of the FHIT gene in human tumor cells (Q41055843)

26 September 2017

title

Protein expression and functional analysis of the FHIT gene in human tumor cells (English)

1 reference

26 September 2017

Otterson GA

1 reference

26 September 2017

Xiao GH

1 reference

26 September 2017

Geradts J

1 reference

26 September 2017

Jin F

1 reference

26 September 2017

Chen WD

1 reference

26 September 2017

Niklinska W

1 reference

26 September 2017

Kaye FJ

1 reference

26 September 2017

Yeung RS

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

Journal of the National Cancer Institute

26 September 2017

published in

1 reference

26 September 2017

1 reference

26 September 2017

1 reference

26 September 2017

page(s)

426-432

1 reference

A nonrandom chromosomal abnormality, del 3p(14–23), in human small cell lung cancer (SCLC)

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Aphidicolin-induced FRA3B breakpoints cluster in two distinct regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

FHIT gene alterations in head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Variable FHIT transcripts in non-neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

NormalFHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

DNA sequencing with chain-terminating inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Identification of a growth suppression domain within the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

The FHIT gene 3p14.2 is abnormal in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

Replacement of Fhit in cancer cells suppresses tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.6.426

21 January 2018

Identifiers

DOI

10.1093/JNCI/90.6.426

1 reference

26 September 2017

1 reference